Short answer
Outset Medical, Inc. (OM) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 earnings announcement for quarter ended September 30, 2026.
Outset Medical, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 earnings announcement for quarter ended September 30, 2026
- Press release furnished as Exhibit 99.1, containing financial results and management commentary
- Earnings conference call scheduled for November 4, 2026
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $33.6M, up 14% YoY and 6% sequentially, supporting continued commercial momentum
- Console revenue $10.5M, up 26% YoY, while recurring revenue reached $23.1M, up 10%
- Gross margin expanded to 40.7% from 39.4%, led by service margin improving to 32.4% from 24.8%
- GAAP net loss narrowed to $14.7M from $17.8M, but non-GAAP net loss widened to $12.9M from $12.4M
- Cash, investments and restricted cash totaled $140.7M after $10.3M quarterly cash use; 2026 revenue guidance reaffirmed at $125M-$130M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Outset Medical, Inc. 8-K filings
Get the next OM 8-K as it lands
Follow OM for push alerts, or ask the research agent what this filing means.